Innoviva, Inc. (INVA)
21.03
-0.04
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
21.00
-0.03
(-0.14%)
After-Hours: 06:37
Innoviva Shareholders Equity (Quarterly) : 1.233B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.233B |
| March 31, 2026 | 1.342B |
| December 31, 2025 | 1.173B |
| September 30, 2025 | 1.010B |
| June 30, 2025 | 714.82M |
| March 31, 2025 | 646.90M |
| December 31, 2024 | 691.16M |
| September 30, 2024 | 668.54M |
| June 30, 2024 | 665.52M |
| March 31, 2024 | 703.68M |
| December 31, 2023 | 674.96M |
| September 30, 2023 | 627.49M |
| June 30, 2023 | 555.09M |
| March 31, 2023 | 561.49M |
| December 31, 2022 | 565.79M |
| September 30, 2022 | 641.37M |
| June 30, 2022 | 388.34M |
| March 31, 2022 | 386.64M |
| December 31, 2021 | 414.74M |
| September 30, 2021 | 402.81M |
| June 30, 2021 | 329.78M |
| March 31, 2021 | 634.46M |
| December 31, 2020 | 539.91M |
| September 30, 2020 | 485.56M |
| June 30, 2020 | 456.91M |
| Date | Value |
|---|---|
| March 31, 2020 | 379.54M |
| December 31, 2019 | 313.50M |
| September 30, 2019 | 267.06M |
| June 30, 2019 | 226.68M |
| March 31, 2019 | 188.24M |
| December 31, 2018 | 153.58M |
| September 30, 2018 | -111.36M |
| June 30, 2018 | -157.36M |
| March 31, 2018 | -213.56M |
| December 31, 2017 | -242.86M |
| September 30, 2017 | -222.96M |
| June 30, 2017 | -296.73M |
| March 31, 2017 | -334.19M |
| December 31, 2016 | -352.99M |
| September 30, 2016 | -367.86M |
| June 30, 2016 | -363.10M |
| March 31, 2016 | -361.97M |
| December 31, 2015 | -342.64M |
| September 30, 2015 | -323.00M |
| June 30, 2015 | -293.99M |
| March 31, 2015 | -260.14M |
| December 31, 2014 | -223.35M |
| September 30, 2014 | -193.14M |
| June 30, 2014 | -187.53M |
| March 31, 2014 | 263.25M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 217.65M |
| Collegium Pharmaceutical, Inc. | 311.91M |
| CorMedix, Inc. | 460.83M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.703B |
| Total Liabilities (Quarterly) | 469.46M |
| Debt to Equity Ratio | 0.2187 |
| Current Ratio | 16.01 |
| Net Debt Paydown Yield | 2.20% |